Added to YB: 2024-04-16
Pitch date: 2024-04-16
LABP [bullish]
Landos Biopharma, Inc.
+6.85%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases.
Market Cap
$71.7M
Pitch Price
$21.46
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-2.88
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
LANDOS BIOPHARMA INC LABP
A summary for this pitch has not been created yet.
Read full article (0 min)